AIHas Artificial Intelligence Revolutionized Drug Design and Discovery? [Volume 12, Issue 2, 2026, Pages 103-106]
AntibacterialGreen synthesis of silver using Eucalyptus camaldulensis leaf extract and evaluation of its antibacterial and antifungal activities [Volume 12, Issue 2, 2026]
AntifungalGreen synthesis of silver using Eucalyptus camaldulensis leaf extract and evaluation of its antibacterial and antifungal activities [Volume 12, Issue 2, 2026]
Antimicrobial resistanceThe Role of Sulfur-Rich Phytochemical Coronas in the Synergistic Green Synthesis of Potent Silver Nanobiocides using Endemic Ferula Species [Volume 12, Issue 2, 2026]
ATR-FTIRFrom HPLC to Chemometric-Assisted Spectroscopy: A Comparative Study of Analytical Approaches [Volume 12, Issue 1, 2026, Pages 17-36]
Bio-molecular coronaThe Role of Sulfur-Rich Phytochemical Coronas in the Synergistic Green Synthesis of Potent Silver Nanobiocides using Endemic Ferula Species [Volume 12, Issue 2, 2026]
Broad-spectrum beta-lactamsPrevalence of Extended-spectrum ß-lactamase-producing Escherichia coli (ESBL E. coli) Among ICU Personnel's Stool Specimens in Teaching Hospitals in Tehran [Volume 12, Issue 1, 2026, Pages 1-8]
C
CardiologyPharmacotherapy in Chronic Coronary Syndromes: Current Evidence and Future Directions. [Volume 12, Issue 1, 2026, Pages 37-54]
Chemometric-assisted spectroscopyFrom HPLC to Chemometric-Assisted Spectroscopy: A Comparative Study of Analytical Approaches [Volume 12, Issue 1, 2026, Pages 17-36]
Chronic coronary syndromePharmacotherapy in Chronic Coronary Syndromes: Current Evidence and Future Directions. [Volume 12, Issue 1, 2026, Pages 37-54]
Computational biologyHas Artificial Intelligence Revolutionized Drug Design and Discovery? [Volume 12, Issue 2, 2026, Pages 103-106]
Continuing Professional DevelopmentA Comprehensive Review of Education and Training in Pharmacogenomics for the Modern Pharmacist [Volume 12, Issue 2, 2026]
Critical careDrug-Drug Interactions Among Pediatric Intensive Care Unit: Risk Factors and Clinical Outcomes [Volume 12, Issue 1, 2026, Pages 93-102]
Curriculum DevelopmentA Comprehensive Review of Education and Training in Pharmacogenomics for the Modern Pharmacist [Volume 12, Issue 2, 2026]
D
DiabetesAn Update on Pharmacological and Clinical Aspects of S-adenosylmethionine in Metabolic Syndrome [Volume 12, Issue 2, 2026, Pages 117-132]
Drug discoveryHas Artificial Intelligence Revolutionized Drug Design and Discovery? [Volume 12, Issue 2, 2026, Pages 103-106]
Drug-induced liver injuryMitochondrial and Redox Mechanisms of Leflunomide-Induced Hepatotoxicity Following Repeated Exposure [Volume 12, Issue 1, 2026, Pages 81-92]
Drug InteractionsDrug-Drug Interactions Among Pediatric Intensive Care Unit: Risk Factors and Clinical Outcomes [Volume 12, Issue 1, 2026, Pages 93-102]
E
ESBLPrevalence of Extended-spectrum ß-lactamase-producing Escherichia coli (ESBL E. coli) Among ICU Personnel's Stool Specimens in Teaching Hospitals in Tehran [Volume 12, Issue 1, 2026, Pages 1-8]
Escherichia coliVector Design, Cloning, and Expression of a Recombinant Immunotoxin Against Vascular Endothelial Growth Factor Containing the Recombinant Anti-Tumor Protein MAP30 in Escherichia coli [Volume 12, Issue 2, 2026]
Escherichia coliGreen synthesis of silver using Eucalyptus camaldulensis leaf extract and evaluation of its antibacterial and antifungal activities [Volume 12, Issue 2, 2026]
Eucalyptus camaldulensisGreen synthesis of silver using Eucalyptus camaldulensis leaf extract and evaluation of its antibacterial and antifungal activities [Volume 12, Issue 2, 2026]
Extracellular MatrixTissue Engineering in Regenerative Medicine: Scaffolds, Biomaterials, and Bio-fabrication Strategies for Clinical Translation [Volume 12, Issue 2, 2026]
F
Ferula assa-foetidaThe Role of Sulfur-Rich Phytochemical Coronas in the Synergistic Green Synthesis of Potent Silver Nanobiocides using Endemic Ferula Species [Volume 12, Issue 2, 2026]
Ferula persicaThe Role of Sulfur-Rich Phytochemical Coronas in the Synergistic Green Synthesis of Potent Silver Nanobiocides using Endemic Ferula Species [Volume 12, Issue 2, 2026]
G
Green synthesisThe Role of Sulfur-Rich Phytochemical Coronas in the Synergistic Green Synthesis of Potent Silver Nanobiocides using Endemic Ferula Species [Volume 12, Issue 2, 2026]
HepatotoxicityMitochondrial and Redox Mechanisms of Leflunomide-Induced Hepatotoxicity Following Repeated Exposure [Volume 12, Issue 1, 2026, Pages 81-92]
HPLCFrom HPLC to Chemometric-Assisted Spectroscopy: A Comparative Study of Analytical Approaches [Volume 12, Issue 1, 2026, Pages 17-36]
HPLC–UVDevelopment and Validation of an Enantioselective HPLC–UV Method for Stereospecific Therapeutic Drug Monitoring of Methadone Enantiomers in Iranian MMT Patients: A Pilot Study [Volume 12, Issue 1, 2026, Pages 67-80]
ImmunotoxinVector Design, Cloning, and Expression of a Recombinant Immunotoxin Against Vascular Endothelial Growth Factor Containing the Recombinant Anti-Tumor Protein MAP30 in Escherichia coli [Volume 12, Issue 2, 2026]
Insulin ResistanceUncoupling the LRP6 V1062I genetic variant from early-onset insulin resistance in a healthy pediatric cohort [Volume 12, Issue 2, 2026]
Intensive care unitDrug-Drug Interactions Among Pediatric Intensive Care Unit: Risk Factors and Clinical Outcomes [Volume 12, Issue 1, 2026, Pages 93-102]
Intensive care unit (ICU)Prevalence of Extended-spectrum ß-lactamase-producing Escherichia coli (ESBL E. coli) Among ICU Personnel's Stool Specimens in Teaching Hospitals in Tehran [Volume 12, Issue 1, 2026, Pages 1-8]
K
Keywords: Pharmaceutical quality controlFrom HPLC to Chemometric-Assisted Spectroscopy: A Comparative Study of Analytical Approaches [Volume 12, Issue 1, 2026, Pages 17-36]
L
LeflunomideMitochondrial and Redox Mechanisms of Leflunomide-Induced Hepatotoxicity Following Repeated Exposure [Volume 12, Issue 1, 2026, Pages 81-92]
Lipid-lowering therapyPharmacotherapy in Chronic Coronary Syndromes: Current Evidence and Future Directions. [Volume 12, Issue 1, 2026, Pages 37-54]
LRP6 geneUncoupling the LRP6 V1062I genetic variant from early-onset insulin resistance in a healthy pediatric cohort [Volume 12, Issue 2, 2026]
M
MAP30 toxinVector Design, Cloning, and Expression of a Recombinant Immunotoxin Against Vascular Endothelial Growth Factor Containing the Recombinant Anti-Tumor Protein MAP30 in Escherichia coli [Volume 12, Issue 2, 2026]
MASHAn Update on Pharmacological and Clinical Aspects of S-adenosylmethionine in Metabolic Syndrome [Volume 12, Issue 2, 2026, Pages 117-132]
Medication errorsDrug-Drug Interactions Among Pediatric Intensive Care Unit: Risk Factors and Clinical Outcomes [Volume 12, Issue 1, 2026, Pages 93-102]
Metabolic SyndromeAn Update on Pharmacological and Clinical Aspects of S-adenosylmethionine in Metabolic Syndrome [Volume 12, Issue 2, 2026, Pages 117-132]
Methadone enantiomersDevelopment and Validation of an Enantioselective HPLC–UV Method for Stereospecific Therapeutic Drug Monitoring of Methadone Enantiomers in Iranian MMT Patients: A Pilot Study [Volume 12, Issue 1, 2026, Pages 67-80]
Mitochondrial dysfunctionMitochondrial and Redox Mechanisms of Leflunomide-Induced Hepatotoxicity Following Repeated Exposure [Volume 12, Issue 1, 2026, Pages 81-92]
N
Nosocomial InfectionPrevalence of Extended-spectrum ß-lactamase-producing Escherichia coli (ESBL E. coli) Among ICU Personnel's Stool Specimens in Teaching Hospitals in Tehran [Volume 12, Issue 1, 2026, Pages 1-8]
O
Oxidative stressMitochondrial and Redox Mechanisms of Leflunomide-Induced Hepatotoxicity Following Repeated Exposure [Volume 12, Issue 1, 2026, Pages 81-92]
P
PCSK9 inhibitorsPharmacotherapy in Chronic Coronary Syndromes: Current Evidence and Future Directions. [Volume 12, Issue 1, 2026, Pages 37-54]
Pediatric Metabolic SyndromeUncoupling the LRP6 V1062I genetic variant from early-onset insulin resistance in a healthy pediatric cohort [Volume 12, Issue 2, 2026]
PediatricsDrug-Drug Interactions Among Pediatric Intensive Care Unit: Risk Factors and Clinical Outcomes [Volume 12, Issue 1, 2026, Pages 93-102]
Personalized MedicineA Comprehensive Review of Education and Training in Pharmacogenomics for the Modern Pharmacist [Volume 12, Issue 2, 2026]
PharmacogenomicsA Comprehensive Review of Education and Training in Pharmacogenomics for the Modern Pharmacist [Volume 12, Issue 2, 2026]
PharmacyPharmacotherapy in Chronic Coronary Syndromes: Current Evidence and Future Directions. [Volume 12, Issue 1, 2026, Pages 37-54]
Pharmacy educationA Comprehensive Review of Education and Training in Pharmacogenomics for the Modern Pharmacist [Volume 12, Issue 2, 2026]
RamanFrom HPLC to Chemometric-Assisted Spectroscopy: A Comparative Study of Analytical Approaches [Volume 12, Issue 1, 2026, Pages 17-36]
S
S-adenosylmethionineAn Update on Pharmacological and Clinical Aspects of S-adenosylmethionine in Metabolic Syndrome [Volume 12, Issue 2, 2026, Pages 117-132]
SilverGreen synthesis of silver using Eucalyptus camaldulensis leaf extract and evaluation of its antibacterial and antifungal activities [Volume 12, Issue 2, 2026]
Silver NanoparticlesThe Role of Sulfur-Rich Phytochemical Coronas in the Synergistic Green Synthesis of Potent Silver Nanobiocides using Endemic Ferula Species [Volume 12, Issue 2, 2026]
UV-VISFrom HPLC to Chemometric-Assisted Spectroscopy: A Comparative Study of Analytical Approaches [Volume 12, Issue 1, 2026, Pages 17-36]
V
VEGFVector Design, Cloning, and Expression of a Recombinant Immunotoxin Against Vascular Endothelial Growth Factor Containing the Recombinant Anti-Tumor Protein MAP30 in Escherichia coli [Volume 12, Issue 2, 2026]
W
Wnt SignalingUncoupling the LRP6 V1062I genetic variant from early-onset insulin resistance in a healthy pediatric cohort [Volume 12, Issue 2, 2026]